AgiBot ranks 4 on the Humanoids 100 with a score of 89; DexForce ranks 9 with 85. AgiBot is ahead on deployment, production and positioning. DexForce is ahead on firepower and leverage. Level on commercials, progress and technology. AgiBot is based in Shanghai, China, DexForce in China. AgiBot: Established. AgiBot is named in 380 signals and DexForce in 26.
AgiBot develops and mass-produces humanoid robots, including the A-Series, G-Series and Lingxi platforms, deployed in logistics, factories, retail and hotels.
Darker bar: ahead of the other company on that measure.
AgiBot (Zhiyuan Robotics; AgiBot Innovation (Shanghai) Technology Co., Ltd.) is a Shanghai-based embodied-AI humanoid maker founded Feb-23 by ex-Huawei executives Deng Taihua (CEO/Chairman) and Peng Zhihui (CTO). It rolled out its 5,000th mass-produced humanoid Dec-8-25 and its 15,000th by Jun-26, and per Omdia was the No.1 global humanoid shipper in 2025 (~5,100 units, ~39% share). It reported group revenue of ~RMB 1.05bn for 2025 and launched a Hong Kong IPO process Jul-24-26 targeting a ~US$5.1–6.4bn valuation; the open question is whether commercial depth matches its production lead.
380 signals name AgiBot.
134 facts on file.
DexForce develops and sells humanoid robots, including the 40-degree-of-freedom W1 Pro, and has shipped thousands of robots for real-world deployments in tourism, cultural venues, retail and service settings.
Darker bar: ahead of the other company on that measure.
DexForce, also known as Kuawei or 跨维智能, is a China-based physical-AI company supplying embodied-intelligence software, 3D perception, simulation/data infrastructure and its own W1 Pro general-purpose humanoid platform. It reported more than 1,000 deployed projects across over 30 cities, a July-2025 A1/A2 financing of several hundred million RMB, a June-2026 RMB 1 billion Series B at a valuation above RMB 10 billion, and W1 Pro production and first delivery through Lenovo's manufacturing network in October-December 2025. Its distinguishing position is a vertically integrated data-to-model-to-robot stack; the open question is how much of reported commercial deployment is autonomous operation versus company-supported or teleoperated delivery.
26 signals name DexForce.
50 facts on file.
AgiBot ranks 4 on the Humanoids 100 with a score of 89; DexForce ranks 9 with 85. AgiBot is ahead on deployment, production and positioning. DexForce is ahead on firepower and leverage. Level on commercials, progress and technology. AgiBot is based in Shanghai, China, DexForce in China. AgiBot: Established. AgiBot is named in 380 signals and DexForce in 26.
AgiBot ranks 4 on the Humanoids 100 with a score of 89; DexForce ranks 9 with 85. AgiBot is ahead on deployment, production and positioning. DexForce is ahead on firepower and leverage. Level on commercials, progress and technology. AgiBot is based in Shanghai, China, DexForce in China. AgiBot: Established. AgiBot is named in 380 signals and DexForce in 26. Both company files carry the scores on eight measures, the facts with sources and the latest signals.
Members see every signal and fact behind both companies, the live ranking, the questions the signals answer and the week explained. $99 a month, 7-day trial. What Frontier Tech Intelligence is →